Registered title, quoted from ClinicalTrials.gov
Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery
An open trial on breast cancer, registered on ClinicalTrials.gov. Led by Second Affiliated Hospital, Zhejiang University; 0 other hospitals on this site are listed as study sites.
Status, phase and start date as registered on ClinicalTrials.gov on 18 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.
The study team’s contact details are on the registry record. This site does not pass on enquiries.
Hospitals in mainland China listed for this trial 1
Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.
The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov
Source: ClinicalTrials.gov record NCT06671249, read on 18 Nov 2026; hospital names matched to this site’s hospital list. How names are matched
Checklist for this trial 4
Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.
Show the checklist (4 points)Hide the checklist
18 years to Not stated; sex: women only
Registered eligibility fields
Preoperative pathologically confirmed invasive breast cancer or ductal carcinoma in situ
Inclusion criterion 2
Clinical classification T1, T2 (maximum tumor diameter ≤5cm)
Inclusion criterion 3
Pregnant and lactating women
Exclusion criterion 8
Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: earlier treatment; day-to-day activity level; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes.
Questions to ask the study team
Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT06671249, read on 10 Nov 2026.
Registered criteria
Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.
Inclusion Criteria:
- Female over the age of 18
- Preoperative pathologically confirmed invasive breast cancer or ductal carcinoma in situ
- Clinical classification T1, T2 (maximum tumor diameter ≤5cm)
- Single-center tumor (preoperative confirmation by B-ultrasound, MRI and other imaging examinations)
- No clinical or imaging evidence of distant metastasis
- Able and willing to sign informed consent
Exclusion Criteria:
- Tumor in the lower inner quadrant
- Tumor in multiple quadrants
- Imaging or intraoperative pathology indicates tumor invasion of the nipple areola, skin, or pectoralis major
- Locally advanced breast cancer patients are undergoing neoadjuvant therapy
- Tumor in multiple quadrants
- Have been participating in other clinical trials, which may affect the participation in this trial
- Previous history of breast cancer (patients with recurrence after ipilateral breast-conserving surgery)
- Pregnant and lactating women
- Patients with severe cardiopulmonary disease or severely impaired lung function are not suitable for surgical establishment of an air cavity
Quoted from ClinicalTrials.gov, NCT06671249, participation criteria. Read on 10 Nov 2026.
Where this information comes from
The registry record
ClinicalTrials.gov (US National Library of Medicine), record NCT06671249, read on 18 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.
Diseases and hospitals
The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions
What is left out
Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.